Real-World Study Suggests Benefits of Cladribine for Older Patients With Multiple Sclerosis Transitioning Off Therapy
A therapy with an intermittent dosing schedule and a finite course may be an option for older patients with multiple sclerosis (MS) as an “exit strategy” to transition off of disease-modifying therapy (DMT). The MS community is confronting the question of …